» Articles » PMID: 23322905

Systems-level Analysis of Proteolytic Events in Increased Vascular Permeability and Complement Activation in Skin Inflammation

Overview
Journal Sci Signal
Date 2013 Jan 17
PMID 23322905
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

During inflammation, vascular permeability is increased by various proteolytic events, such as the generation of bradykinin, that augment local tissue responses by enabling tissue penetration of serum proteins, including complement and acute-phase proteins. Proteases also govern inflammatory responses by processing extracellular matrix proteins and soluble bioactive mediators. We quantified changes in the proteome and the nature of protein amino termini (the N-terminome) and the altered abundance of murine proteases and inhibitors during skin inflammation. Through analysis of the N-terminome by iTRAQ-TAILS, we identified cotranslational and posttranslational αN-acetylation motifs, quantitative increases in protein abundance, and qualitative changes in the proteolytic signature during inflammation. Of the proteins identified in normal skin, about half were cleaved, and phorbol ester-induced inflammation increased the proportion of cleaved proteins, including chemokines and complement proteins, that were processed at previously uncharacterized sites. In response to phorbol ester-induced inflammation, mice deficient in matrix metalloproteinase 2 (MMP2) showed reduced accumulation of serum proteins in the skin and exhibited different proteolytic networks from those of wild-type mice. We found that the complement 1 (C1) inhibitor attenuated the increase in serum protein accumulation in inflamed skin. Cleavage and inactivation of the C1 inhibitor by MMP2 increased complement activation and bradykinin generation in wild-type mice, leading to increased vessel permeability during inflammation, which was diminished in Mmp2(-/-) mice. Thus, our systems-level analysis of proteolysis dissected cleavage events associated with skin inflammation and demonstrated that loss of a single protease could perturb the proteolytic signaling network and enhance inflammation.

Citing Articles

TMT-proteomics reveals the therapeutic effects of Lianling decoction against atopic dermatitis through infection.

Zhang L, Fan Z, Li L, Sun Z Heliyon. 2024; 10(19):e38381.

PMID: 39403467 PMC: 11471467. DOI: 10.1016/j.heliyon.2024.e38381.


Identification of the proteolytic signature in CVB3-infected cells.

Vlok M, Solis N, Sadasivan J, Mohamud Y, Warsaba R, Kizhakkedathu J J Virol. 2024; 98(7):e0049824.

PMID: 38953667 PMC: 11265341. DOI: 10.1128/jvi.00498-24.


Redefining metalloproteases specificity through network proteolysis.

Kollet O, Das A, Karamanos N, Auf dem Keller U, Sagi I Trends Mol Med. 2023; 30(2):147-163.

PMID: 38036391 PMC: 11004056. DOI: 10.1016/j.molmed.2023.11.001.


Integrative modeling of diverse protein-peptide systems using CABS-dock.

Pulawski W, Kolinski A, Kolinski M PLoS Comput Biol. 2023; 19(7):e1011275.

PMID: 37405984 PMC: 10351741. DOI: 10.1371/journal.pcbi.1011275.


Post-translational Modifications of the Protein Termini.

Chen L, Kashina A Front Cell Dev Biol. 2021; 9:719590.

PMID: 34395449 PMC: 8358657. DOI: 10.3389/fcell.2021.719590.


References
1.
Dean R, Overall C . Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics. 2007; 6(4):611-23. DOI: 10.1074/mcp.M600341-MCP200. View

2.
Lee Y, Lee Y, Kim B, Shin Y, Nam S, Kim P . ECgene: an alternative splicing database update. Nucleic Acids Res. 2006; 35(Database issue):D99-103. PMC: 1716719. DOI: 10.1093/nar/gkl992. View

3.
Doucet A, Butler G, Rodriguez D, Prudova A, Overall C . Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome. Mol Cell Proteomics. 2008; 7(10):1925-51. DOI: 10.1074/mcp.R800012-MCP200. View

4.
Riddel Jr J, Aouizerat B, Miaskowski C, Lillicrap D . Theories of blood coagulation. J Pediatr Oncol Nurs. 2007; 24(3):123-31. DOI: 10.1177/1043454206298693. View

5.
Kaplan A, Ghebrehiwet B . The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010; 47(13):2161-9. DOI: 10.1016/j.molimm.2010.05.010. View